Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2R | P25116 | 2/20 | 0.70 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.64 |
| ▸ | NMUR2 | Q9GZQ4 | 14/20 | 0.64 |
| ▸ | NMUR1 | Q9HB89 | 13/20 | 0.64 |
| ▸ | NPY1R | P25929 | 1/20 | 0.59 |
| ▸ | NPY2R | P49146 | 1/20 | 0.59 |
| ▸ | NPY4R | P50391 | 1/20 | 0.59 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29494603 | 0.91 | NMUR2 (0.66) | F2RNMUR2NMUR1NPY1R | |
| SCHEMBL30634738 | 0.88 | NMUR2 (0.56) | F2ROPRK1NMUR2NMUR1NPY1R | |
| SCHEMBL30454432 | 0.86 | OPRK1 (0.53) | F2ROPRK1NMUR2NMUR1 | |
| SCHEMBL30157061 | 0.85 | NMUR2 (0.66) | NMUR2NMUR1 | |
| SCHEMBL29519178 | 0.85 | NMUR2 (0.79) | OPRK1NMUR2NMUR1NPY1R | |
| SCHEMBL29359131 | 0.84 | NPY1R (0.69) | F2ROPRK1NMUR2NMUR1NPY1R | |
| SCHEMBL29618668 | 0.84 | NPY1R (0.64) | OPRK1NMUR2NMUR1NPY1RNPY2R | |
| SCHEMBL27076913 | 0.84 | NPY1R (0.69) | F2ROPRK1NMUR2NMUR1NPY1R | |
| SCHEMBL29666880 | 0.84 | OPRK1 (0.58) | OPRK1NMUR2NMUR1 | |
| SCHEMBL3539226 | 0.83 | NMUR2 (0.71) | OPRK1NMUR2NMUR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3943127-A1 | HEMOSTATIC MATERIAL | Baxter International Inc (US) | 2022-01-26 | — | — | EP | claimed |
| US-12618852-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2026-05-05 | — | — | US | disclosed |
| US-20260049992-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | AMBERGEN INC (US) | 2026-02-19 | — | — | US | disclosed |
| EP-4686477-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING PNS INJURY AND DEGENERATIVE DISEASES | AdRegeneer (CH) | 2026-02-04 | — | — | EP | disclosed |
| EP-4544307-A1 | METHOD OF DIAGNOSING WOUNDS | Trauma Care Consult Traumatologische Forschung Gemeinnützige Gesellschaft mbH (AT) | 2025-04-30 | — | — | EP | disclosed |
| CN-119630968-A | Method for diagnosing wounds | 创伤护理咨询创伤学研究有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20250067751-A1 | PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | AMBERGEN INC (US) | 2025-02-27 | — | — | US | disclosed |
| US-12235277-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | AMBERGEN, INC. (US) | 2025-02-25 | — | — | US | disclosed |
| US-12181482-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | AMBERGEN, INC. (US) | 2024-12-31 | — | — | US | disclosed |
| US-12181481-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | AMBERGEN, INC. (US) | 2024-12-31 | — | — | US | disclosed |
| US-20220365098-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | AMBERGEN, INC | 2022-11-17 | — | — | US | disclosed |
| US-20220365097-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | AMBERGEN, INC. | 2022-11-17 | — | — | US | disclosed |
| CN-108883191-B | Antibody-conjugates with improved therapeutic index for targeting CD30 tumors and methods for improving the therapeutic index of antibody-conjugates | 西纳福克斯股份有限公司 | 2022-10-14 | — | — | CN | disclosed |
| CN-115135669-A | Modified Fc region | 艾迪沃有限责任公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-112718271-B | Gravity vortex filter | 中国科学院合肥物质科学研究院 | 2022-08-12 | — | — | CN | disclosed |
| US-20220137066-A1 | PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-05-05 | — | — | US | disclosed |
| US-20220135518-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-05-05 | — | — | US | disclosed |
| US-20220137064-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-05-05 | — | — | US | disclosed |
| US-20220137065-A1 | PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-05-05 | — | — | US | disclosed |
| EP-3943127-A1 | HEMOSTATIC MATERIAL | Baxter International Inc (US) | 2022-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220365098-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | CD44, MKI67, MSH2 | F2R 968/4885OPRK1 4799/4885NMUR2 1868/4885 |
| US-12235277-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | CD44, MKI67, CD68 | F2R 900/4885OPRK1 4817/4885NMUR2 2131/4885 |
| US-20260049992-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | MKI67, CD44, MUC1 | F2R 724/4885OPRK1 4521/4885NMUR2 1527/4885 |
| US-12618852-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | CD44, CD68, EPCAM | F2R 1441/4885OPRK1 4769/4885NMUR2 2318/4885 |
| US-12181481-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | CD44, MKI67, CD68 | F2R 900/4885OPRK1 4817/4885NMUR2 2131/4885 |
| US-20220365097-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | CD44, MKI67, MSH2 | F2R 968/4885OPRK1 4799/4885NMUR2 1868/4885 |
| US-20220135518-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | CD44, MKI67, MSH2 | F2R 968/4885OPRK1 4799/4885NMUR2 1868/4885 |
| US-20250067751-A1 | PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | CD44, MKI67, CD68 | F2R 900/4885OPRK1 4817/4885NMUR2 2131/4885 |
| US-12181482-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | MKI67, MSH2, MSH6 | F2R 3535/4885OPRK1 4869/4885NMUR2 3165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.